Organic nanocarrier-integrated polymeric microneedle patches for localized management of multiple diseases
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Dermatologic Treatments and Research · Microbial Inactivation Methods
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Drug delivery systems: past, present, and future10.2174/1389450043345407 ↗
2. Targeted drug delivery strategies for precision medicines10.1038/s41578-020-00269-6 ↗
3. Design of nano-delivery systems for pancreatic cancer immunotherapy10.1016/j.canlet.2025.218098 ↗
4. Nanoscale systems for local drug delivery10.1016/j.nantod.2019.100765 ↗
5. Reconstituted high density lipoprotein (rHDL), a versatile drug delivery nanoplatform for tumor targeted therapy10.1039/D0TB02139C ↗
6. Compacted solid implant formulations for long-term buprenorphine delivery10.1016/j.jconrel.2026.114722 ↗
7. Nanocarrier-based systems for targeted and site specific therapeutic delivery10.1016/j.addr.2019.07.010 ↗
8. Microfluidic-Enabled Assembly of Multicomponent Artificial Organelle for Synergistic Tumor Starvation Therapy10.1021/acsami.4c07962 ↗
9. Local scaffold-assisted delivery of immunotherapeutic agents for improved cancer immunotherapy10.1016/j.addr.2022.114308 ↗
10. A precision-guided MWNT mediated reawakening the sunk synergy in RAS for anti-angiogenesis lung cancer therapy10.1016/j.biomaterials.2017.05.046 ↗
11. A dual-targeting drug co-delivery system for tumor chemo- and gene combined therapy10.1016/j.msec.2016.03.083 ↗
12. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy10.1016/j.biomaterials.2012.08.057 ↗
13. An enzyme-responsive and NIR-triggered lipid-polymer hybrid nanoplatform for synergistic photothermal/chemo cancer therapy10.1039/D2BM00216G ↗
14. Versatile carbon nanoplatforms for cancer treatment and diagnosis: strategies, applications and future perspectives10.7150/thno.69628 ↗
15. Stage-specific therapeutic strategies for combating bacterial biofilm infections: Recent advances and future perspectives10.1016/j.jconrel.2026.114815 ↗
16. Microneedles for advanced ocular drug delivery10.1016/j.addr.2023.115082 ↗
17. Microneedle system for tissue engineering and regenerative medicine10.1002/EXP.20210170 ↗
18. From conceptual design to translational progress: Emerging advances in intelligent microneedles for biomedical applications10.1016/j.apsb.2026.01.021 ↗
19. Microneedle biomedical devices10.1038/s44222-023-00141-6 ↗
20. Wearable microneedle-based electrochemical aptamer biosensing for precision dosing of drugs with narrow therapeutic windows10.1126/sciadv.abq4539 ↗
21. Microneedle-based device for the one-step painless collection of capillary blood samples10.1038/s41551-018-0194-1 ↗
22. Advances in the application of microneedles in the treatment of local organ diseases
23. Microneedle-mediated cell therapy
24. Synthetic biology-instructed transdermal microneedle patch for traceable photodynamic therapy10.1038/s41467-022-33837-1 ↗
25. Dissolvable polymer microneedles for drug delivery and diagnostics10.1016/j.jconrel.2022.04.043 ↗
26. Polymer modification effects in nanocarrier-loaded dissolving microneedles: Implications for transdermal drug delivery
27. Microneedle-based cell delivery and cell sampling for biomedical applications10.1016/j.jconrel.2023.09.013 ↗
28. Microneedle-mediated vaccination: innovation and translation10.1016/j.addr.2021.113919 ↗
29. Dynamic regulation of drug biodistribution by turning tumors into decoys for biomimetic nanoplatform to enhance the chemotherapeutic efficacy of breast cancer with bone metastasis10.1002/EXP.20220124 ↗
30. The progress in the application of dissolving microneedles in biomedicine10.3390/polym15204059 ↗
31. Macrophage membrane-camouflaged lipoprotein nanoparticles for effective obesity treatment based on a sustainable self-reinforcement strategy10.1016/j.actbio.2022.08.055 ↗
32. Strategies for organic nanoparticles delivering CRISPR/Cas9 for cancer therapy: Challenges and breakthroughs10.1016/j.matdes.2024.113097 ↗
33. A dual-targeting reconstituted high density lipoprotein leveraging the synergy of sorafenib and antimiRNA21 for enhanced hepatocellular carcinoma therapy10.1016/j.actbio.2018.05.049 ↗
34. Biomimetic HDL nanoparticle mediated tumor targeted delivery of indocyanine green for enhanced photodynamic therapy10.1016/j.colsurfb.2016.09.037 ↗
35. Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis10.1016/j.biomaterials.2014.05.009 ↗
36. Natural compound-driven nano-self-assembly for multimechanistic transdermal antiobesity therapy10.1021/acsnano.5c20129 ↗
37. Fibronectin-coated metal–phenolic networks for cooperative tumor chemo-/chemodynamic/immune therapy via enhanced ferroptosis-mediated immunogenic cell death10.1021/acsnano.1c08585 ↗
38. State of the art for cardiotoxicity due to chemotherapy and to targeted therapies: A literature review10.1016/j.critrevonc.2013.02.007 ↗
39. Nanoparticle-mediated targeted drug delivery to remodel tumor microenvironment for cancer therapy10.2147/IJN.S321416 ↗
40. Advances in targeted therapy for tumor with nanocarriers: a review
41. Insights on functionalized carbon nanotubes for cancer theranostics10.1186/s12951-021-01174-y ↗
42. Immune‐engineered hydrogels combat orthotopic and metastatic cancer via hypoxia‐relieved photodynamic therapy and ferroptotic cell death10.1002/adfm.202529034 ↗
43. Rapidly dissolving microneedle patch embedded with long-acting microspheres for sustained release of goserelin10.1016/j.jconrel.2025.114397 ↗
44. Advanced and innovative nano-systems for anticancer targeted drug delivery10.3390/pharmaceutics13081151 ↗
45. Combination of nanomaterials in cell-based drug delivery systems for cancer treatment10.3390/pharmaceutics13111888 ↗
46. Suppression of PARP1 enhances PTEN mRNA therapy in castration-resistant prostate cancer by glycolysis disruption
47. An on-demand oxygen nano-vehicle sensitizing protein and nucleic acid drug augment immunotherapy
48. Black phosphorus, an emerging versatile nanoplatform for cancer immunotherapy10.3390/pharmaceutics13091344 ↗
49. Harnessing nanobiotechnology for cerebral ischemic stroke management10.1039/D2BM01790C ↗
50. Splenic dendritic cell-targeting mRNA transfection of H-type ionizable lipid-based LNPs for enhancing tumor immunotherapy
51. Ultrasound-activatable lipid nanoplatform for region-confined innate immune stimulation and mrna vaccination therapy of cancer
52. An antigen-capturing and lymph node-targeting nanoparticle for cancer immunotherapy10.1016/j.jconrel.2025.01.087 ↗
53. Dissolving microneedles: applications and growing therapeutic potential10.1016/j.jconrel.2022.05.045 ↗
54. Hyaluronan: a simple polysaccharide with diverse biological functions10.1016/j.actbio.2013.12.019 ↗
55. Hyaluronic acid association with bacterial, fungal and viral infections: can hyaluronic acid be used as an antimicrobial polymer for biomedical and pharmaceutical applications?
56. Hyaluronic acid for anticancer drug and nucleic acid delivery10.1016/j.addr.2015.11.011 ↗
57. Two-pronged attack: dual activation of fat reduction using near-infrared-responsive nanosandwich for targeted anti-obesity treatment10.1002/advs.202406985 ↗
58. Chemically modified biopolymers for the formation of biomedical hydrogels10.1021/acs.chemrev.0c00923 ↗
59. Versatile hydrogel-based drug delivery platform for multimodal cancer therapy from bench to bedside
60. Thiolated polymeric hydrogels for biomedical application: Cross-linking mechanisms10.1016/j.jconrel.2020.12.037 ↗
61. Chemoimmunotherapeutic nanogel for pre- and postsurgical treatment of malignant melanoma by reprogramming tumor-associated macrophages10.1021/acs.nanolett.3c04563 ↗
62. NIR light-triggered chemo-phototherapy by icg functionalized MWNTs for synergistic tumor-targeted delivery10.3390/pharmaceutics13122145 ↗
63. Amphoteric hyaluronic acid derivative for targeting gene delivery10.1016/j.biomaterials.2010.08.043 ↗
64. Tip-loaded fast-dissolving microneedle patches for photodynamic therapy of subcutaneous tumor10.1016/j.jconrel.2018.07.038 ↗
65. Microneedles containing cross-linked hyaluronic acid particulates for control of degradation and swelling behaviour after administration into skin10.1080/1061186X.2018.1435664 ↗
66. Systematic comparisons of dissolving and swelling hyaluronic acid microneedles in transdermal drug delivery10.1016/j.ijbiomac.2021.09.161 ↗
67. Gelatin carriers for drug and cell delivery in tissue engineering10.1016/j.jconrel.2014.04.014 ↗
68. Characterization of porous collagen/hyaluronic acid scaffold modified by 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide cross-linking10.1016/S0142-9612(01)00235-6 ↗
69. Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels10.1016/j.biomaterials.2015.08.045 ↗
70. Preparation and characterization of chitosan/gelatin/PVA hydrogel for wound dressings10.1016/j.carbpol.2016.03.002 ↗
71. A chitosan/fucoidan nanoparticle-loaded pullulan microneedle patch for differential drug release to promote wound healing10.1016/j.carbpol.2023.120593 ↗
72. Endogenous stimuli-responsive separating microneedles to inhibit hypertrophic scar through remodeling the pathological microenvironment10.1038/s41467-024-46328-2 ↗
73. Chitosan-based microneedles as a potential platform for drug delivery through the skin: Trends and regulatory aspects10.1016/j.ijbiomac.2021.06.059 ↗
74. Chitin and derivative chitosan-based structures - preparation strategies aided by deep eutectic solvents: A review10.1016/j.carbpol.2021.118702 ↗
75. Recent developments in antibacterial and antifungal chitosan and its derivatives10.1016/j.carbpol.2017.02.001 ↗
76. A chitosan-graft-PEI-candesartan conjugate for targeted co-delivery of drug and gene in anti-angiogenesis cancer therapy10.1016/j.biomaterials.2014.06.025 ↗
77. G.G. d′Ayala, Wound healing and antimicrobial effect of active secondary metabolites in chitosan-based wound dressings: A review10.1016/j.carbpol.2020.115839 ↗
78. Cholesterol and fat lowering with hydrophobic polysaccharide derivatives10.1016/j.carbpol.2014.05.009 ↗
79. Tuning chitosan's chemical structure for enhanced biological functions10.1016/j.tibtech.2022.11.009 ↗
80. Rapid induction of long-lasting systemic and mucosal immunity via thermostable microneedle-mediated chitosan oligosaccharide-encapsulated DNA oparticles10.1021/acsnano.3c09521 ↗
81. Antibacterial and angiogenic chitosan microneedle array patch for promoting wound healing
82. Materials fabrication from Bombyx mori silk fibroin10.1038/nprot.2011.379 ↗
83. Silk fibroin for skin injury repair: Where do things stand?10.1016/j.addr.2019.09.003 ↗
84. Silk fibroin formed bioadhesive ophthalmic gel for dry eye syndrome treatment10.1208/s12249-024-02792-z ↗
85. Silk fibroin-based biomaterials for cartilage/osteochondral repair10.7150/thno.74548 ↗
86. Ancient fibrous biomaterials from silkworm protein fibroin and spider silk blends: Biomechanical patterns10.1016/j.actbio.2022.09.030 ↗
87. A mussel-inspired supramolecular hydrogel with robust tissue anchor for rapid hemostasis of arterial and visceral bleedings
88. Stabilization of natural antioxidants by silk biomaterials10.1021/acsami.6b01636 ↗
89. Silk chemistry and biomedical material designs10.1038/s41570-023-00486-x ↗
90. Silk microneedle patch capable of on-demand multidrug delivery to the brain for glioblastoma treatment
91. Silk fibroin microneedle patches for the treatment of insomnia10.3390/pharmaceutics13122198 ↗
92. Marine polymeric microneedles for transdermal drug delivery10.1016/j.carbpol.2021.118098 ↗
93. Advances in natural polymer-based transdermal drug delivery systems for tumor therapy10.1002/smll.202301670 ↗
94. Click cross-linking improves retention and targeting of refillable alginate depots10.1016/j.actbio.2020.05.033 ↗
95. A theranostic microneedle array patch for integrated glycemia sensing and self-regulated release of insulin10.1039/D1BM01834E ↗
96. A sustainable solution to skin diseases: ecofriendly transdermal patches10.3390/pharmaceutics15020579 ↗
97. Strong and stiff: high-performance cellulose nanocrystal/poly(vinyl alcohol) composite fibers10.1021/acsami.6b11578 ↗
98. The use of cellulose, chitosan and hyaluronic acid in transdermal therapeutic management of obesity: a review10.1016/j.ijbiomac.2023.125374 ↗
99. Biomimetic cellulose-based superabsorbent hydrogels for treating obesity
100. Ethyl cellulose and hydroxypropyl methyl cellulose blended methotrexate-loaded transdermal patches: in vitro and ex vivo10.3390/polym13203455 ↗